Egis Division to Develop, Produce Active Ingredients for Partners
French-owned Hungarian pharmaceutical company Egis Gyógyszergyár on Tuesday announced the launch of a new division to develop and produce active ingredients for industry peers as a contracted partner, according to a report by state news wire MTI.
Egis unveiled its new business, dubbed Egis Pharma Services, at the industry trade fair CPHI taking place in Barcelona on October 24-26.
Egis noted that its R&D and production activities are conducted solely in Hungary.
Egis CEO Csaba Poroszlai said the company's vertically integrated structure gave Egis a big advantage.
Egis had revenue of HUF 219 billion in its business year ended September 30.
Erste Bank Hungary Q1 Earnings Close to HUF 29 bln
Hungary Welcomes Extension of China's Visa Exemption Policy
Living's Kassák Terrace and Park West 3 Classified as Brownf...
Aldi Opening Biggest Store in Budapest
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
